Influence of psychological response on survival in breast cancer: a population-based cohort study by Watson, M. et al.
THE LANCET • Vol 354 • October 16, 1999 1331
S u m m a r y
B a c k g r o u n d The psychological response to breast cancer,
such as a fighting spirit or an attitude of helplessness and
hopelessness toward the disease, has been suggested as a
prognostic factor with an influence on survival. We have
investigated the effect of psychological response on disease
outcome in a large cohort of women with early-stage breast
c a n c e r .
M e t h o d s 578 women with early-stage breast cancer were
enrolled in a prospective survival study. Psychological response
was measured by the mental adjustment to cancer (MAC)
scale, the Courtauld emotional control (CEC) scale, and the
hospital anxiety and depression (HAD) scale 4–12 weeks and
12 months after diagnosis. The women were followed up for at
least 5 years. Cox’s proportional-hazards regression was used
to obtain the hazard ratios for the measures of psychological
response, with adjustment for known clinical factors
associated with survival.
F i n d i n g s At 5 years, 395 women were alive and without
relapse, 50 were alive with relapse, and 133 had died. There
was a significantly increased risk of death from all causes by 5
years in women with a high score on the HAD scale category of
depression (hazard ratio 3·59 [95% CI 1·39–9·24]). There was
a significantly increased risk of relapse or death at 5 years in
women with high scores on the helplessness and
hopelessness category of the MAC scale compared with those
with a low score in this category (1·55 [1·07–2·25]). There
were no significant results found for the category of “fighting
s p i r i t ” .
I n t e r p r e t a t i o n For 5-year event-free survival a high
helplessness/hopelessness score has a moderate but
detrimental effect. A high score for depression is linked to a
significantly reduced chance of survival; however, this result is
based on a small number of patients and should be
interpreted with caution.
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I n t r o d u c t i o n
There have been many suggestions of a role for
psychological response in the outcome of cancer, but little
scientific evidence. A few studies examined the influence of
psychiatric symptoms on disease outcome in patients with
breast cancer. The presence of psychiatric symptoms,
including emotional distress, was significantly related to
poorer prognosis in two studies,1 , 2 whereas three found no
relation between psychiatric symptoms and disease
o u t c o m e .3 – 5 These studies were limited by their small
sample size (most had fewer than 200 patients) or short
period of follow-up, so reliable assessment of the effect of
psychological response in women with early-stage breast
cancer is difficult.
A few studies suggested that women who develop breast
cancer may be more likely than those who do not to
suppress negative emotions6 – 8—the type C personality.
Subsequent research suggested a cancer-prone personality
type characterised by abnormal inhibition of emotions and
inability to express anger.9 Despite flimsy evidence for the
cancer-prone personality, this research has been
enthusiastically received by the lay press and by
practitioners of alternative therapies. This psychological
response has been implicated as a factor that may influence
the development of cancer, but whether it is also associated
with survival is not known. In one of the earliest prospective
studies of psychological response and survival in breast
cancer, Greer and colleagues found a significant link
between prognosis and psychological response.1 0 P a t i e n t s
whose psychological responses were categorised as fighting
spirit or denial were significantly more likely to be alive and
relapse-free 5 years after diagnosis of an early-stage breast
cancer than those whose response was of helplessness or
stoic acceptance. These results were still significant at the
10-year follow-up.1 1 Nevertheless, this early study has
several shortcomings: there were only 57 patients and there
was no adjustment for the important prognostic variable of
lymph-node status, because few data on node status were
available at the beginning of the study. Furthermore, the
original assessment of psychological response was restricted
to a brief open-ended question rather than a more detailed
and psychometrically reliable measure.
Our study aimed to replicate these findings in a large
cohort, with a prevalidated assessment of psychological
response, and control for all known prognostic factors. In
addition, we investigated whether there were any
associations between the individual dimensions of the
mental adjustment to cancer (MAC) scale and overall or
event-free survival, and similarly for the Courtauld
emotional control (CEC) scale. Women were followed up
for a minimum of 5 years.
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M e t h o d s
P a r t i c i p a n t s
Women with early-stage breast cancer (stages I and II) who
presented consecutively at the Royal Marsden Hospital, London
and Sutton, UK, were invited to participate in the study. Eligibility
criteria for the cohort were: age between 18 and 75 years; ability to
complete a questionnaire; awareness of their cancer diagnosis; no
apparent serious intellectual impairment; and diagnosis 4–12 weeks
before the inclusion date. All patients meeting the eligibility criteria
were identified from hospital records and approached during their
normal hospital outpatient visits, when they were asked if they
would be willing to take part in a study assessing the emotional and
psychological impact of cancer. Local research ethics committee
approval was obtained before the start of the study. Of the patients
surveyed, 658 (95%) agreed to participate in the psychological
assessment. Of these, 55 were not eligible because they had already
relapsed between the point of identification for entry and the
psychological assessment. 16 women were later confirmed as
having non-invasive breast cancer and in nine women there was
inadequate information to confirm whether the cancer was invasive.
Therefore, the final cohort for the 5-year survival analyses consisted
of 578 patients with confirmed invasive breast cancer.
P r o c e d u r e
Patients were assessed by self-administered questionnaires selected
for validity, reliability, and previous use in this population.
Participants completed the study measures at 4–12 weeks after
diagnosis and 1 year later. The patients were recruited into the
study in the context of screening for eligibility for a psychological
intervention study, and were unaware of the hypotheses being
investigated in this follow-up study. This approach reduced any
bias in the reporting of psychological response. The questionnaires
w e r e :
MAC scale1 2— This brief 40-item questionnaire was developed to
assess patients’ reactions to having cancer in five dimensions:
fighting spirit, helplessness or hopelessness, anxious preoccupation,
fatalism, and avoidance (the latter two being previously labelled as
stoic acceptance and denial1 3). Fighting spirit is characterised by a
determination to fight the illness and adopt an optimistic attitude
(eg, “I see my illness as a challenge”). Patients showing a response
of helplessness or hopelessness may feel engulfed by knowledge of
the diagnosis and have a wholly pessimistic attitude (eg, “I feel like
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Characteristic Number of patients
Age (years)
<50 172 (29·8%)
50–59 187 (32·4%)
60–69 185 (32·0%)
70 34 (5·9%)
Menopausal status
Premenopausal 156 (27·0%)
Perimenopausal 38 (6·6%)
Postmenopausal 369 (63·8%)
Unknown 15 (2·6%)
WHO performance status rating
Grade 0 338 (58·5%)
Grade 1 205 (35·5%)
Grade 2 31 (5·4%)
Grade 3 2 (0·3%)
Unknown 2 (0·3%)
Tumour diameter (mm)
2·00 266 (46·0%)
2·00–4·99 152 (26·3%)
5·00 35 (6·1%)
Unknown 125 (21·6%)
Number of lymph nodes positive
0 210 (36·3%)
1–3 114 (19·7%)
4–9 31 (5·4%)
10 19 (3·3%)
Unknown - not done 198 (34·3%)
Unknown - no data 6 (1·0%)
Oestrogen-receptor status
Positive 99 (17·1%)
Negative 87 (15·1%)
Unknown 392 (67·8%)
Histopathological grade
I - well differentiated 31 (5·4%)
II - moderately differentiated 149 (25·8%)
III - poorly differentiated 167 (28·9%)
Lobular 40 (6·9%)
Unknown 191 (33·0%)
Operation and radiotherapy
Mastectomy, no radiotherapy 45 (7·8%)
Mastectomy and radiotherapy 49 (8·5%)
Lumpectomy, no radiotherapy 8 (1·4%)
Lumpectomy and radiotherapy 449 (77·7%)
Unknown 27 (4·7%)
Chemotherapy, endocrine therapy, or both
Yes 461 (79·8%)
No 115 (19·9%)
Unknown 2 (0·3%)
Table 1: Demographic and clinical characteristics at enrolment
(n=578)
Figure 1: Overall and event-free survival according to
predominant response on the MAC scale
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giving up”). This measure, which has been independently
v a l i d a t e d ,1 4 , 1 5 showed  high concordance with the clinical interview
assessment method used by Greer and colleagues.1 3 M e n t a l
adjustment to cancer, as assessed by this measure, involves the
tendency to cope with the stress of cancer in a particular way and
has been found to be significantly associated with measures of
depression and anxiety.1 6
CEC scale1 7—This scale assesses the extent to which patients
suppress negative emotions; a focal variable of the suggested type C
cancer-prone personaility. The questionnaire assesses the tendency
to respod to feelings of anxiety, sadness, and anger by suppressing
or controlling reactions when these emotions are experienced.
Hospital anxiety and depression scale (HAD)1 8—This widely used
screening tool assesses anxiety and depression as two dimensions
and has been validated in cancer patients.1 9
Data were collected from medical records on initial disease
stage, type of treatment, and disease outcome 5 years after study
entry. Medical information was missing in some cases because it
was not recorded in the medical notes. The most common reason
for absence of data was that they had not been collected at the time
of breast-cancer diagnosis.
Statistical methods
The MAC scale was analysed in two different ways. First, to
replicate the analysis of Greer and colleagues,1 0 each patient was
classified as having one predominant response from the categories
of fighting spirit, helplessness or hopelessness, anxious
preoccupation, and fatalism. To classify a patient’s predominant
response, each of the MAC subscale scores was converted to a z-score
according to the mean and SD. Each patient was then assigned to a
group representing her predominant response according to the
MAC subscale with the highest standardised score. Where no
standardised score was greater than zero (ie, the sample mean), the
patient was classified as having no predominant response. The
avoidance subscale was not included in this categorisation because
it consists of only one item from the MAC questionnaire, and
calculation of a standardised score is not feasible.
Second, each of the individual MAC subscales was
dichotomised with standard cut-off scores (according to the
guidelines of the developers of the test)2 0 to define cases (ie, patients
judged to be at high psychological risk on this assessment). The
cut-off scores correspond to the value of the mean plus 1 SD, for
each individual subscale, as defined in the MAC users manual.1 2
For the HAD scale, each of the subscale scores (anxiety and
depression) was divided into three categories: 0–7 (non-case); 8–10
(borderline case); and 11 or more (case).1 8
Relapse data were only recorded if relapse occurred within 5
years of enrolment into the study, so all our analyses were
truncated at 5 years, although mortality data were collected beyond
5 years of follow-up. Kaplan-Meier survival methods were used to
obtain estimates of survival and event-free survival at 5 years, and
the log-rank test was used to test for significance between survival
curves of the various categories of psychological response. Cox’s
proportional-hazards regression models were fitted to obtain the
hazard ratios (together with 95% CI) for the measures of
psychological response, with adjustement for clinical factors that
are associated with overall and event-free survival in breast cancer:
histopathological grade, number of positive lymph nodes, tumour
size, type of operation, whether the patient received chemotherapy
or endocrine therapy, and oestrogen-receptor status.
The psychological measures were also assessed in regression
analyses as covariates (ie, with the original uncategorised scores),
but because the results were extremely similar to those obtained
with the categorical data, only the latter results are presented. To
use the updated psychological response data collected at 1 year of
follow-up, regression models were fitted in exactly the same way for
the initial analyses, but the MAC and HAD scales were fitted as
time-dependent factors. We checked the assumptions of
proportional hazards by plotting the cumulative hazard functions
for each category of the psychological measures.
The significance of our findings must be interpreted with
caution owing to the number of statistical tests done. All
hypotheses relating to the associations between each individual
psychological measure, and overall or event-free survival were
stated a priori.
The Cox’s proportional-hazards regression analyses of overall
survival were repeated with all available data on follow-up and
deaths (ie, data beyond 5 years) but the results were very similar to
those obtained for 5-year overall survival and so only the latter
results are presented.
R e s u l t s
578 breast-cancer patients were enrolled into the study
(table 1). The mean age of the women was 55 years
( S D 10·6). Of the 415 women for whom social class could
be defined, 282 (68%) were in classes I to III-non manual.
64% were married.
The overall median follow-up was 4·93 years (IQR
4·58–5·18). 160 (27·7%) women relapsed and in these
women the median time to relapse was 2·12 years
(1·08–3·25). 133 (23·0%) had died by 5 years of follow-up,
122 (21·1%) of breast cancer. In the remaining 11 women,
cause of death could not be ascertained from the hospital,
general practitioner, or cancer registry records. For the
analyses of event-free survival, 173 (29·9%) had died from
breast cancer or relapsed by 5 years. Therefore, at 5 years
395 (68·3%) patients were alive and without relapse, 50
(8·7%) were alive with relapse, and 133 (23·0%) had died.
Figure 2: Overall and event-free survival according to score on
MAC category ‘helplessness and hopelessness’
There were no significant effects of psychological
response on overall or event-free survival. Comparisons that
attempted to replicate previous findings1 0 showed no
significant association between the predominant response in
the MAC scale and overall (p=0·73) or event-free survival
(p=0·63), with exclusion of women with a missing response
(data missing on the MAC sub-scales; figure 1, table 2).
I n analysis with dichotomised scores for each individual
psychological response on the MAC scale, a helplessness
o r hopelessness score was associated with increased risk
o f death or relapse over the 5 years of follow-up, with
t h e results for event-free survival reaching statistical
significance (overall survival; p=0·08, and event-free
survival p<0·01; figure 2). In regression analyses there was
a significant effect of a high score on the MAC helplessness
or hopelessness subscale on event-free survival (p<0·01),
which decreased slightly after adjustment for prognostic
f a c t o r s .
A high score on the depression subscale of the HAD scale
was significantly associated with overall survival in regression
analysis (p<0·05), and the effect became stronger after
adjustment for prognostic factors (p<0·01; table 3). For
event-free survival the effect of a high score on the depression
subscale of the HAD scale was not significant (table 4).
Psychological assessments at 1 year of follow-up were
available for 455 women, although there were varying
amounts of missing data for some of the individual scores.
The number of women who had the same category of MAC
predominant response at 1 year as at baseline was 202
(47·3%) of 427 women with follow-up data. However, the
proportion of women remaining in the same category (ie,
above or below the cut-off point that defined a case) was
much higher for the individual MAC and HAD scale
scores, ranging from 77% for MAC fighting spirit and 86%
for helplessness or hopelessness to 96% for depression in
the HAD scale (p<0·001 for all  s t a t i s t i c s ) .
Because the baseline and follow-up psychological data
were all highly correlated, we would not expect the results
of a survival analysis that takes into account the time-
dependency of the data, to produce results very different
from the analyses that only used enrolment data. However,
such models were fitted with Cox’s proportional-hazards
regression with time-dependent factors for the updated
MAC and HAD scale scores to verify this expectation. With
adjustment for the same set of clinical prognostic factors as
in the previous analyses, the following minor differences
from the previous analysis of baseline psychological data
were observed. For overall survival, the increased risk of
death during follow-up for the HAD scale category of
depression remained significant (adjusted hazard ratio 4·04
[95% CI 1·54–10·64] for a score of 11 on HAD scale
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Deaths/total (death rate) Crude hazard ratio (95% CI) Adjusted hazard ratio (95% CI)*
MAC scale predominant responses
None 10/50 (20%) 1·00 1·00
Fighting spirit 35/166 (21%) 1·03 (0·51–2·07) 0·86 (0·42–1·76)
Helplessness/hopelessness 29/127 (23%) 1·21 (0·59–2·49) 0·95 (0·46–1·98)
Anxious preoccupation 30/120 (25%) 1·28 (0·62–2·61) 1·04 (0·50–2·17)
Fatalism 27/99 (27%) 1·41 (0·68–2·92) 1·02 (0·49–2·15)
Unknown 2/16 (13%) 0·58 (0·13–2·67) 0·37 (0·08–1·71)
MAC—fighting spirit
>47 94/412 (23%) 1·00 1·00
47 39/162 (24%) 1·10 (0·76–1·60) 1·11 (0·76–1·62)
MAC—helplessness/hopelessness
<12 106/486 (22%) 1·00 1·00
12 27/91 (30%) 1·45 (0·95–2·22) 1·30 (0·84–2·00)
MAC—anxious preoccupation
<26 113/507 (22%) 1·00 1·00
26 19/69 (28%) 1·29 (0·80–2·11) 1·21 (0·73–2·00)
MAC—fatalism
<23 116/512 (23%) 1·00 1·00
23 16/60 (27%) 1·19 (0·70–2·01) 1·04 (0·61–1·79)
MAC—avoidance
<4 123/544 (23%) 1·00 1·00
4 8/29 (28%) 1·23 (0·60–2·52) 1·53 (0·72–3·28)
HADS—anxiety
0–7 86/407 (21%) 1·00 1·00
8–10 27/102 (27%) 1·29 (0·83–1·98) 1·35 (0·86–2·11)
11 20/68 (29%) 1·47 (0·91–2·40) 1·54 (0·93–2·56)
HADS—depression
0–7 123/541 (23%) 1·00 1·00
8–10 5/27 (19%) 0·80 (0·33–1·95) 0·74 (0·30–1·84)
11 5/10 (50%) 2·52 (1·03–6·16)† 3·59 (1·39–9·24)‡
*Adjusted for histopathological grade, number of positive lymph nodes, tumour size, type of operation received, chemotherapy and/or endocrine therapy, oestrogen-receptor status, and age.
†p<0·05; ‡p<0·01.
Table 3: Results of Cox’s proportional-hazards regression analysis for baseline psychological measures and overall survival at 5 years
Alive with no Alive with Dead Total
recurrence recurrence (n=133) (n=578)
(n=395) (n=50)
MAC predominant response
None 37 (74%) 3 (6%) 10 (20%) 50
Fighting spirit 117 (70%) 14 (8%) 35 (21%) 166
Helplessness/hopelessness 82 (65%) 16 (13%) 29 (23%) 127
Anxious preoccupation 81 (68%) 9 (8%) 30 (25%) 120
Fatalism 64 (65%) 8 (8%) 27 (27%) 99
Unknown 14 (88%) 0 2 (13%) 16
HADS anxiety
0–7 283 (70%) 38 (9%) 86 (21%) 407
8–10 67 (66%) 8 (8%) 27 (27%) 102
11 44 (65%) 4 (6%) 20 (29%) 68
Unknown 1 0 0 1
HADS depression
0–7 370 (68%) 48 (9%) 123 (23%) 541
8–10 20 (74%) 2 (7%) 5 (19%) 27
11 5 (50%) 0 5 (50%) 10
Percentages are row percentages.
Table 2: 5-year outcome according to baseline MAC
predominant response scores and HAD scale scores
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depression). For event-free survival the effect of MAC
helplessness or hopelessness was reduced from before (1·35
[0·91–2·00]), and was no longer significant. The CEC scale
scores showed no significant associations with overall or
event-free survival (data not shown).
D i s c u s s i o n
In this large population-based cohort study, the
psychological data are largely free from measurement bias
because the women were approached in the context of
screening for an intervention trial2 1 rather than an
observational study of the association between their
psychological response and survival, and so they were
unaware of the study hypothesis. Only one patient was lost
to follow-up after 5 years. Several questionnaires were used
in the data collection, and the psychological assessments
were repeated at 1 year of follow-up. We attempted to
replicate the results reported by Greer and colleagues1 0 b u t
could find no survival difference when comparing one type
of psychological response with another. There was no effect
on survival of high versus low MAC scores for the category
of fighting spirit.
There was no significant effect of scores for emotional
control on survival. Although suppression of negative
emotions has been suggested as a focal characteristic of the
type C cancer-prone personality, we could find no evidence
that this tendency has any effect on survival in this group.
There was a significant association between a
helplessness or hopelessness response and relapse-free
survival at 5 years. With control for known prognostic
factors, this effect was reduced but remained significant.
Patients who had a high score on the helpless measure at
baseline were more likely to have relapsed or died during
the 5 years. When we examined this effect with
psychological scores assessed 1 year later, the association of
the helpless response with relapse-free survival remained
but was no longer significant, perhaps because some
women’s scores changed from the high to low helpless
category (compared with baseline) thereby reducing the
numbers available for analysis. The results for the HAD
scale category of depression indicated increased risk of
death by 5 years in women with high initial scores and, after
adjustment for known clinical prognostic factors, this
association was strengthened. The number of women
scoring in the clinically depressed range at baseline (ie,
defined as a score of 11) was small (2%).
The idea that an attitude of fighting spirit, in relation to
cancer, improves overall length of survival has been
embraced with enthusiasm, especially by practitioners of
alternative therapies. Fighting spirit (as assessed here on the
MAC scale) was not associated with improved survival in
this study; such claims should be far more cautious and
circumspect. Our findings suggest that women can be
relieved of the burden of guilt that occurs when they find it
difficult to maintain a fighting spirit. Further research is
needed to clarify whether positive psychological responses
not assessed by the MAC scale could have a role in breast-
cancer prognosis.
Our results raise several questions. The observed
association between helplessness or hopefulness and
depression, as early responses to breast cancer, with
subsequent overall prognosis requires explanation. A few
significant results could have occurred purely by chance
because a large number of tests have been done. Hence we
have presented for all the hazard-ratio estimates rather than
showing exact p values, because CIs are more interpretable
where multiple significance testing has occurred. The
number of women scoring in the depressed range (11) for
Cancer deaths or Crude hazard ratio (95% CI) Adjusted hazard ratio (95% CI)*
relapses/total (event rate)
MAC predominant responses
None 12/50 (24%) 1·00 1·00
Fighting spirit 47/166 (28%) 1·18 (0·63–2·23) 1·00 (0·52–1·91)
Helplessness/hopelessness 41/127 (32%) 1·43 (0·75–2·72) 1·15 (0·60–2·22)
Anxious preoccupation 39/120 (33%) 1·41 (0·74–2·70) 1·08 (0·55–2·11)
Fatalism 33/99 (33%) 1·52 (0·78–2·94) 1·20 (0·62–2·36)
Unknown 1/16 (6%) 0·23 (0·03–1·79) 0·14 (0·02–1·12)
MAC—fighting spirit
>47 122/412 (30%) 1·00 1·00
47 51/162 (32%) 1·11 (0·80–1·54) 1·13 (0·81–1·58)
MAC—helplessness/hopelessness
<12 135/486 (28%) 1·00 1·00
12 38/91 (42%) 1·64 (1·13–2·32)† 1·55 (1·07–2·25)‡
MAC—anxious preoccupation
<26 151/507 (30%) 1·00 1·00
26 22/69 (32%) 1·10 (0·70–1·72) 0·99 (0·62–1·58)
MAC—fatalism
<23 154/512 (30%) 1·00 1·00
23 18/60 (30%) 1·00 (0·61–1·62) 0·96 (0·58–1·59)
MAC—avoidance
<4 163/544 (30%) 1·00 1·00
4 8/29 (28%) 0·94 (0·46–1·91) 1·16 (0·55–2·46)
HADS—anxiety
0–7 117/407 (29%) 1·00 1·00
8–10 33/102 (32%) 1·16 (0·79–1·71) 1·16 (0·78–1·74)
11 23/68 (34%) 1·22 (0·77–1·87) 1·20 (0·75–1·91)
HADS—depression
0–7 162/541 (30%) 1·00 1·00
8–10 7/27 (26%) 0·82 (0·39–1·75) 0·76 (0·35–1·64)
11 4/10 (40%) 1·55 (0·57–4·18) 2·02 (0·73–5·64)
*Adjusted for histopathological grade, number of positive lymph nodes, tumour size, type of operation received, chemotherapy and/or endocrine therapy, oestrogen-receptor status, and age.
†p<0·05; ‡p<0·01.
Table 4: Results of Cox’s proportional-hazards regression analysis for baseline psychological measures and event-free survival at 5 years
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the HAD scale was small (2%). This small sample, and the
wide CIs, suggest that more evidence is needed before we
can conclude that depression has a significant effect on
survival. Replication of this study with a larger sample of
depressed patients would be worthwhile.
The effect of helplessness or hopelessness, although
modest, is more robust because a large number of patients
were in this category and the CIs were narrower. We
suggest several explanations for the association between the
helplessness or hopelessness response and event-free
survival. First, psychological response may influence
biological response via immune function. However, the link
between immunosuppression and breast-cancer progression
remains unproven. Second, the direct effect of
psychological response on stress hormones (eg, prolactin)
which might have an effect on disease processes, could be
investigated. Third, psychological response may moderate
important aspects of social functioning. Patients who hold a
helpless attitude may be less proactive in obtaining the
amount of health care needed to obtain the maximum
possible survival and this effect needs to be investigated.
Finally, the biology of the tumour may have caused the
psychological response assessed at baseline, although we
know of no evidence that supports this explanation. Further
studies should investigate possible explanatory mechanisms.
Whatever the explanatory mechanisms, Greer and
colleagues have already shown in a randomised trial the
helplessness or hopelessness response can be improved by
the use of cognitive-behavioural therapy.2 1 This type of brief
psychological therapy can be used to bring improvements in
the degree of helplessness experienced by some patients and
possibly in length of survival, although we have not tested
the latter hypothesis.
These data indicate that a helpless response along with
known clinical prognostic factors has a modest association
with poorer survival. Our results need to be put in context.
Although this study is large compared with previous studies
of psychological response and survival, the trial is smaller
than most trials of adjuvant therapy, most of which have at
least 1000 patients. Hence, with 578 patients in this study,
the actual effect of psychological response on survival would
have to be greater than the effect of adjuvant therapy (eg,
about 10% absolute improvement in 10-year survival for
t a m o x i f e n2 2 to show a highly significant result). The small
number of patients scoring in the HAD scale clinical range
also limits the analysis, and although a significant effect was
found, a conclusive result will require replication in a larger
sample of depressed patients.
Although the association between a response of
helplessness or hopelessness and disease outcome observed
in this study is modest, the association is not trivial. For
clinicians treating breast-cancer patients, the results
reinforce the need to detect a response of helplessness or
hopelessness and serious depression, and treat these
responses vigorously to help women improve quality of life
and optimise length of survival.
The data reported here will help clarify the question of
whether psychological response has an effect on survival.
The negative finding in relation to the fighting spirit
response is important and the association between
helplessness and survival reinforces the need to ensure there
is adequate provision of psychological care within oncology
aimed at encouraging patients to feel less helpless and
h o p e l e s s .
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